Mayurbhai Patel

VP of CMC and Chemistry Development at Judo Bio

Speaker

Mayurbhai (Mayur) Patel leads Chemistry Development and CMC at Judo Bio, where he oversees oligonucleotide process development, analytical strategy, formulation, large-scale manufacturing, and supply chain. He brings more than a decade of experience in nucleic acid chemistry and CMC and has developed scalable manufacturing processes for 15+ oligonucleotide programs spanning preclinical through late-stage clinical development.

Prior to Judo Bio, Dr. Patel was Director of Oligonucleotide Chemistry and CMC at Korro Bio, where he built and led cross-functional teams across synthesis, analytics, formulation, and CMC, and led CMC strategy for the company’s first clinical program in alpha-1 antitrypsin deficiency. Earlier, he contributed to a broad RNA therapeutics portfolio at Nitto Denko Avecia. Dr. Patel earned his PhD in nucleic acid chemistry from Seton Hall University, has authored numerous publications in RNA therapeutics, and currently serves on the Editorial Advisory Board of Nucleic Acid Insights.